Monday, September 21, 2026

Copper Futures Bearish Momentum With A 1% Fall In The Last 24 Hours

Copper Futures Bearish Momentum With A 1% Fall In The Last 24 Hours

Copper is currently on bearish momentum. At 06:04 EST on Saturday, 10 April, Copper is at $4.05 and 1.21% down since the last session's close.

Copper Range

Regarding Copper's daily highs and lows, it's 0.136% down from its trailing 24 hours low of $4.05 and 1.064% down from its trailing 24 hours high of $4.09.

Volatility

Copper's last week, last month's, and last quarter's current volatility was a positive 0.11%, a negative 0.27%, and a positive 1.22%, respectively.

Copper's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.32% (last week), 1.47% (last month), and 1.22% (last quarter), respectively.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,299 source documents archived
Query this data → isubstrate.com